Back to Search Start Over

The link between chronic cocaine use, B cell perturbations, and blunted immune recovery in HIV-infected individuals on suppressive ART.

Authors :
Cheng D
Luo Z
Fitting S
Stoops W
Heath SL
Ndhlovu LC
Jiang W
Source :
NeuroImmune pharmacology and therapeutics [NeuroImmune Pharm Ther] 2023 Mar 25; Vol. 2 (1), pp. 71-79. Date of Electronic Publication: 2023 Mar 27.
Publication Year :
2023

Abstract

Background: We recently reveal that anti-CD4 autoantibodies contribute to blunted CD4+ T cell reconstitution in HIV+ individuals on antiretroviral therapy (ART). Cocaine use is common among HIV+ individuals and is associated with accelerated disease progression. However, the mechanisms underlying cocaine-induced immune perturbations remain obscure.<br />Methods: We evaluated plasma levels of anti-CD4 IgG and markers of microbial translocation, as well as B-cell gene expression profiles and activation in HIV+ chronic cocaine users and non-users on suppressive ART, as well as uninfected controls. Plasma purified anti-CD4 IgGs were assessed for antibody-dependent cytotoxicity (ADCC).<br />Results: HIV+ cocaine users had increased plasma levels of anti-CD4 IgGs, lipopolysaccharide (LPS), and soluble CD14 (sCD14) versus non-users. An inverse correlation was observed in cocaine users, but not non-drug users. Anti-CD4 IgGs from HIV+ cocaine users mediated CD4+ T cell death through ADCC in vitro . B cells from HIV+ cocaine users exhibited activation signaling pathways and activation (cycling and TLR4 expression) related to microbial translocation versus non-users.<br />Conclusions: This study improves our understanding of cocaine associated B cell perturbations and immune failure and the new appreciation for autoreactive B cells as novel therapeutic targets.<br />Competing Interests: Competing interests: The authors declare no competing financial interests.<br /> (© 2023 the author(s), published by De Gruyter, Berlin/Boston.)

Details

Language :
English
ISSN :
2750-6665
Volume :
2
Issue :
1
Database :
MEDLINE
Journal :
NeuroImmune pharmacology and therapeutics
Publication Type :
Academic Journal
Accession number :
37027536
Full Text :
https://doi.org/10.1515/nipt-2022-0019